Skip to search formSkip to main contentSkip to account menu

roxadustat

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

FG-4592

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Roxadustat and Anemia of Chronic Kidney Disease.
Until 1989, when recombinant erythropoietin therapy was first approved, anemia of chronic kidney disease could be treated only… 
2018
2018
Detection of novel metabolite for Roxadustat doping by global metabolomics.
Roxadustat (FG-4592, Rox) is a stabilizer for hypoxia-inducible transcription factors (HIFs), which induce production of the… 
2018
2018
Serine metabolism is a key pathway involved in the prevention of oxygen-induced retinopathy by Roxadustat
2018
2018
Detection of novel metabolite for roxadustat doping by global metabolomics.
2017
2017
Benchtop Flow Cytometry Facilitates Discrimination Between Induction of DNA Damage , Oxidative Stress , and Protein Misfolding Using a Novel Multicell GFP Reporter Assay
With an increasing demand for the production of novel compounds for a wide range of pharmaceutical, chemical, and cosmetics… 
2016
2016
Therapy: PHD inhibitors correct anaemia in CKD
suggest that oral hypoxia-inducible factor prolyl hydroxylase (PHD) inhibitors might be effective therapies for anaemia in… 
2016
2016
Graphical Synthetic Routes of Roxadustat
2016
2016
Roxadustat: ¿corrige la anemia en pacientes incidentes en hemodiálisis?
2015
2015
FP390MODERATE HEPATIC IMPAIRMENT HAS ONLY A MINOR IMPACT ON THE PHARMACOKINETICS OF ROXADUSTAT, AN ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL-HYDROXYLASE INHIBITOR
2014
2014
Roxadustat. Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, treatment of anemia
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)